Lubna Adeeb, Nadeem Ishaq, Zamir Iqbal, Farah Akhtar, Muhammad Aamir Arain.
Outcomes of Intravitreal Bevacizumab Injections as Primary Treatment for Diabetic Macular Edema.
Al-Shifa J Ophthalmol Jan ;15(4):22-6.

A Quasi Experimental Study was performed to evaluate change in visual acuity and decrease in central macular thickness after using Intravitreal Bevacizumab (IVB) in primary treatment of diabetic macular edema (DME). Diagnosed diabetic patients and no history of any previous treatment for DME were included. Efficacy of treatment was compared in terms of change in BCVA and CSFT on OCT. Intravitreal injection of 1.25 mg of IVB was given on Day 0 and then monthly for next two months. Follow up was done after 04 weeks of third injection.

PakMediNet -Pakistan's largest Database of Pakistani Medical Journals - http://www.pakmedinet.com